Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience
Luigi Gargiulo, Luciano Ibba, Carlo Alberto Vignoli, Paola Facheris, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Topics & Concepts
MedicineAtopic dermatitisQuality of life (healthcare)DermatologyDupilumabPediatricsNursingDermatology and Skin DiseasesAllergic Rhinitis and SensitizationAsthma and respiratory diseases